Patients JP Morgan 2023 – Fred Turner Fred Turner is CEO of Curative, a company that’s just announced a head-scratching pivot: from COVID-testing company to large-group commercial health plan.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.